These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 15853821)

  • 1. Expression of growth hormone-releasing hormone receptor splicing variants in human primary adrenocortical tumours.
    Freddi S; Arnaldi G; Fazioli F; Scarpelli M; Appolloni G; Mancini T; Kola B; Bertagna X; Mantero F; Collu R; Boscaro M
    Clin Endocrinol (Oxf); 2005 May; 62(5):533-8. PubMed ID: 15853821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of growth hormone-releasing hormone and its receptor splice variants in human prostate cancer.
    Halmos G; Schally AV; Czompoly T; Krupa M; Varga JL; Rekasi Z
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4707-14. PubMed ID: 12364462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of GHRH receptor and its splice variant 1 in human normal and malignant mucosa of the oesophagus and colon.
    Hohla F; Moder A; Mayrhauser U; Hauser-Kronberger C; Schally AV; Varga JL; Zarandi M; Buchholz S; Huber R; Aigner E; Ritter M; Datz C
    Int J Oncol; 2008 Jul; 33(1):137-43. PubMed ID: 18575759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of growth hormone-releasing hormone receptor splice variant 1 in primary human melanomas.
    Chatzistamou I; Volakaki AA; Schally AV; Kiaris H; Kittas C
    Regul Pept; 2008 Apr; 147(1-3):33-6. PubMed ID: 18255167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and possible implication of growth hormone-releasing hormone receptor splice variant 1 in endometriosis.
    Fu L; Osuga Y; Yano T; Takemura Y; Morimoto C; Hirota Y; Schally AV; Taketani Y
    Fertil Steril; 2009 Jul; 92(1):47-53. PubMed ID: 18684444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of growth hormone-releasing hormone (GHRH) and splice variant of GHRH receptors in normal mouse tissues.
    Christodoulou C; Schally AV; Chatzistamou I; Kondi-Pafiti A; Lamnissou K; Kouloheri S; Kalofoutis A; Kiaris H
    Regul Pept; 2006 Sep; 136(1-3):105-8. PubMed ID: 16781787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
    Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
    Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The growth hormone-releasing hormone (GHRH) antagonist JV-1-36 inhibits proliferation and survival of human ectopic endometriotic stromal cells (ESCs) and the T HESC cell line.
    Annunziata M; Grande C; Scarlatti F; Deltetto F; Delpiano E; Camanni M; Ghigo E; Granata R
    Fertil Steril; 2010 Aug; 94(3):841-9. PubMed ID: 19524226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression of the pituitary growth hormone-releasing hormone receptor and its splice variants in normal and neoplastic human tissues.
    Havt A; Schally AV; Halmos G; Varga JL; Toller GL; Horvath JE; Szepeshazi K; Köster F; Kovitz K; Groot K; Zarandi M; Kanashiro CA
    Proc Natl Acad Sci U S A; 2005 Nov; 102(48):17424-9. PubMed ID: 16299104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Growth Hormone-Releasing Hormone and Its Receptor Splice Variants in Primary Human Endometrial Carcinomas: Novel Therapeutic Approaches.
    Szabo Z; Juhasz E; Schally AV; Dezso B; Huga S; Hernadi Z; Halmos G; Kiss C
    Molecules; 2022 Apr; 27(9):. PubMed ID: 35566020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the receptors for chicken GHRH and GHRH-related peptides: identification of a novel receptor for GHRH and the receptor for GHRH-LP (PRP).
    Wang Y; Li J; Wang CY; Kwok AY; Zhang X; Leung FC
    Domest Anim Endocrinol; 2010 Jan; 38(1):13-31. PubMed ID: 19748756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor.
    Barabutis N; Siejka A; Schally AV; Block NL; Cai R; Varga JL
    J Mol Endocrinol; 2010 Feb; 44(2):127-34. PubMed ID: 19897610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examination of the direct effects of metabolic factors on somatotrope function in a non-human primate model, Papio anubis.
    Luque RM; Gahete MD; Valentine RJ; Kineman RD
    J Mol Endocrinol; 2006 Aug; 37(1):25-38. PubMed ID: 16901921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of a high-glucose environment on the pituitary growth hormone-releasing hormone receptor: type 1 diabetes compared with in vitro glucotoxicity.
    Bédard K; Strecko J; Thériault K; Bédard J; Veyrat-Durebex C; Gaudreau P
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E740-51. PubMed ID: 18285528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of growth hormone-releasing hormone (GHRH) and its receptor splice variants in human breast cancer lines; the evaluation of signaling mechanisms in the stimulation of cell proliferation.
    Garcia-Fernandez MO; Schally AV; Varga JL; Groot K; Busto R
    Breast Cancer Res Treat; 2003 Jan; 77(1):15-26. PubMed ID: 12602901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of alternatively spliced messenger ribonucleic acid encoding truncated growth hormone-releasing hormone receptor in human pituitary adenomas.
    Hashimoto K; Koga M; Motomura T; Kasayama S; Kouhara H; Ohnishi T; Arita N; Hayakawa T; Sato B; Kishimoto T
    J Clin Endocrinol Metab; 1995 Oct; 80(10):2933-9. PubMed ID: 7559877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of two novel chicken GHRH receptor splice variants: implications for the roles of aspartate 56 in the receptor activation and direct ligand receptor interaction.
    Wang CY; Wang Y; Kwok AH; Leung FC
    J Endocrinol; 2007 Dec; 195(3):525-36. PubMed ID: 18000314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antagonists of growth-hormone-releasing hormone: an emerging new therapy for cancer.
    Schally AV; Varga JL; Engel JB
    Nat Clin Pract Endocrinol Metab; 2008 Jan; 4(1):33-43. PubMed ID: 18084344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the pituitary growth hormone-releasing hormone receptor in ageing male and female LOU rats: new insights into healthy ageing.
    Veyrat-Durebex C; Alliot J; Gaudreau P
    J Neuroendocrinol; 2005 Nov; 17(11):691-700. PubMed ID: 16218997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibition.
    Köster F; Engel JB; Schally AV; Hönig A; Schröer A; Seitz S; Hohla F; Ortmann O; Diedrich K; Buchholz S
    Breast Cancer Res Treat; 2009 Jul; 116(2):273-9. PubMed ID: 18629632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.